Most Recent
Construction PRO
Parkview points finger at architect, surveyor in Australia Towers cladding claim
Parkview Constructions is seeking to bring negligence claims against Bates Smart and McKenzie Group in a lawsuit over alleged combustible cladding at Australia Towers in Sydney Olympic Park. 
Construction PRO
Court rejects developer’s bid for extra time to settle $95M Hyde Park property deal
A developer seeking to redevelop the site of the Hyde Park Inn has lost its bid for an extra 15 months to pay up over $95 million to the NSW branch of the RSL to settle the purchase, but a judge has handed it a win in the process for determining the final price tag for the deal.
Construction PRO
Developer wins $200M in challenge to Sydney Metro compulsory land acquisition
Coombes Property Group has been awarded $200 million in compensation for Sydney Metro’s compulsory acquisition of its CBD property, despite contending it was entitled to $430 million.
Construction PRO
Insurer defeats $13M claim by Parklea development owners corporation
The owners corporation of a 98-unit Parklea development by defunct builder Dyldam Developments has failed in its attempt to claim insurance for building defects in a property completed 17 years ago, with a court finding that time was up. 
Spotless denies ACCC’s price-fixing claims, says Ventia not a competitor
Downer EDI subsidiary Spotless has rejected allegations it engaged in price-fixing with Ventia on defence contracts, saying the facilities services companies were not in competition with each other.
Dovetail denies harassment claim, says lawyer had ‘consensual loving relationship’ with CEO
Dovetail has hit back at a lawsuit alleging its boss sexually assaulted the tech start-up’s female legal counsel, claiming it was a “consensual loving relationship”.
Court lifts 5-year stay of claims against doctors by J&J pelvic mesh patients
A judge has lifted a five-year stay imposed on two cases brought against individual gynaecologists by group members in a resolved class action against Johnson & Johnson over allegedly defective pelvic mesh implants.
Sandoz moves to block Amgen’s attorneys from prosecuting patents in IP spat
Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen's bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.
No contrition, but Fortrend avoids big penalties in spat with Shaw & Partners pair
A judge has ordered Fortrend Securities to pay $181,000 in penalties after finding it unlawfully withheld the bonuses of two financial advisers who jumped ship to rival Shaw & Partners, saying the lower penalties were appropriate despite "not a word of contrition”.